Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 9Terminated 4Recruiting 2Unknown 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 2

Conditions

Carcinoma, Non-Small-Cell Lung 431Breast Neoplasms 300Neoplasms 297Colorectal Neoplasms 245Neoplasm Metastasis 193Ovarian Neoplasms 173Lung Neoplasms 151Prostatic Neoplasms 149Recurrence 147Pancreatic Neoplasms 143Multiple Myeloma 134Stomach Neoplasms 130Squamous Cell Carcinoma of Head and Neck 128Melanoma 123Endometrial Neoplasms 119Leukemia, Myeloid, Acute 114Advanced Solid Tumors 113Advanced Solid Tumor 111Triple Negative Breast Neoplasms 103Carcinoma, Hepatocellular 102Uterine Cervical Neoplasms 90Small Cell Lung Carcinoma 88Lymphoma, Non-Hodgkin 84Carcinoma, Renal Cell 72Lymphoma, Follicular 71Lymphoma 69Leukemia, Lymphocytic, Chronic, B-Cell 65Solid Tumor 64Lymphoma, Large B-Cell, Diffuse 64Esophageal Neoplasms 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × INDUSTRY × Metastatic Castration Resistant Prostate Cancer × Clear all
NCT07093801 2026-05-15

Observational Study on Lutetium (177Lu) Vipivotide Tetraxetan to Treat Metastatic Castration Resistant Prostate Cancer

Novartis

Recruiting
300 enrolled
Genitourinary

Metastatic Castration Resistant Prostate Cancer

NCT06830850 2026-01-15

A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer

Atridia Pty Ltd.

Phase 1 Recruiting
25 enrolled
Genitourinary

Metastatic Castration Resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡